BioLife Solns (NASDAQ:BLFS) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated BioLife Solns and provided 12-month price targets. The average target is $29.75, accompanied by a high estimate of $32.00 and a low estimate of $27.00. Marking an increase of 2.59%, the current average surpasses the previous average price target of $29.00.
Deciphering Analyst Ratings: An In-Depth Analysis
The...
Login or create a forever free account to read this news
Sign up/Log in
